Samsara BioCapital, L.P., 10% Owner at Mineralys Therapeutics, Inc. (MLYS), bought 1,111,110 shares at $13.50 ($15.0M) on 2024-02-12, disclosed to the SEC on 2024-02-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.50 | 555,555 | $7.5M | 50.0% |
| 2 | $13.50 | 555,555 | $7.5M | 50.0% |
| Total | $13.50 avg | 1,111,110 | $15.0M | 100% |
| Filing → |
| GRPH | BUY | 2021-12-20 | $455K | — | Filing → |
| GRPH | BUY | 2021-10-15 | $668K | — | Filing → |